Xichen Lin - 03 Mar 2026 Form 4 Insider Report for Structure Therapeutics Inc. (GPCR)

Role
CHIEF SCIENTIFIC OFFICER
Signature
/s/ Jun Yoon, Attorney-in-Fact
Issuer symbol
GPCR
Transactions as of
03 Mar 2026
Net transactions value
$0
Form type
4
Filing time
05 Mar 2026, 18:20:11 UTC
Previous filing
20 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Lin Xichen CHIEF SCIENTIFIC OFFICER C/O STRUCTURE THERAPEUTICS INC., 601 GATEWAY BLVD., SUITE 900, SOUTH SAN FRANCISCO /s/ Jun Yoon, Attorney-in-Fact 05 Mar 2026 0001962926

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GPCR Ordinary Shares Tax liability -18,735 -9.2% $20.99* 185,592 03 Mar 2026 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer.
F2 Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a restricted share unit award.